Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency in Korean Infants.
10.3346/jkms.2007.22.6.952
- Author:
Jae Sung KO
1
;
Jung Han SONG
;
Sung Sup PARK
;
Jeong Kee SEO
Author Information
1. Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. jkseo@snu.ac.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Cholestasis;
Citrin;
Citrullinemia;
SLC25A13;
Mutation
- MeSH:
Amino Acids/blood;
Calcium-Binding Proteins/*deficiency;
Cholestasis, Intrahepatic/*etiology/genetics;
Citrullinemia/genetics;
Humans;
Infant;
Membrane Transport Proteins/genetics;
Mitochondrial Proteins/genetics;
Mutation;
Organic Anion Transporters/*deficiency
- From:Journal of Korean Medical Science
2007;22(6):952-956
- CountryRepublic of Korea
- Language:English
-
Abstract:
Citrin is a liver-type mitochondrial aspartate-glutamate carrier encoded by the SLC25A13 gene, and its deficiency causes adult-onset type II citrullinemia and neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). Here, the authors investigated clinical findings in Korean infants with NICCD and performed mutation analysis on the SLC25A13 gene. Of 47 patients with neonatal cholestasis, three infants had multiple aminoacidemia (involving citrulline, methionine, and arginine) and galactosemia, and thus were diagnosed as having NICCD. Two of these three showed failure to thrive. The laboratory findings showed hypoproteinemia and hyperammonemia, and liver biopsies revealed micro-macrovesicular fatty liver and cholestasis. The three patients each harbored compound heterozygous 1,638-1,660 dup/ S225X mutation, compound heterozygous 851del4/S225X mutation, and heterozygous 1,638-1,660 dup mutation, respectively. With nutritional manipulation, liver functions were normalized and catch-up growth was achieved. NICCD should be considered in the differential diagnosis of cholestatic jaundice in Korean infants.
